The abstract is read at the publisher; the summary is JClub's.
Evidence on medication safety during pregnancy remains scarce because pregnant people have historically been excluded from clinical trials, limiting reliable guidance for medication use.
- Why it matters: The lack of safety data creates an evidence gap, and trial inclusion is difficult, so timely real-world evidence is needed to inform medication decisions during pregnancy.
- What they did: The work argues that observational studies may be the most effective and timely way to address this gap, while emphasizing the need for guidelines that optimize how such studies are used.
- The result: Clearer guidance for observational evidence is proposed as a way to close the pregnancy medication safety gap more effectively and sooner than relying on trials alone.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.